Copyright
©The Author(s) 2025.
World J Diabetes. Feb 15, 2025; 16(2): 94861
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.94861
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.94861
Figure 1 Dynamics of C-peptide and hemoglobin A1c level of the proband.
A: The fasting and postprandial C-peptide (CP) levels were measured after the type 2 diabetes mellitus (T2D) onset; B: The C-peptide levels (ΔCP = postprandial C-peptide-fasting C-peptide) were calculated after the T2D onset; C: The changes in hemoglobin A1c levels were tested after the T2D onset. DM: Diabetes mellitus; CP: C-peptide; HbA1c: Hemoglobin A1c.
- Citation: Yi B, Bao Y, Wen ZY. Effect of SPTLC1 on type 2 diabetes mellitus. World J Diabetes 2025; 16(2): 94861
- URL: https://www.wjgnet.com/1948-9358/full/v16/i2/94861.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i2.94861